Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, in association with the John Black Charitable Foundation, is pleased to welcome Dr Ira Milosevic as a John Black Senior Research Fellow in Parkinson’s Disease Research.

Ira Milosevic

The John Black Senior Research Fellowship aims to build on the strengths of the University's Central Nervous System (CNS) research programmes and world leading research into the discovery and translation of novel therapeutic approaches for neurodegenerative diseases, with a particular focus on Parkinson's disease. As a principal investigator, Dr Milosevic will provide strategic and academic leadership, pioneering studies and development of worldwide scientific collaborations.

"My colleagues and I are delighted to be welcoming Dr Milosevic to the University of Oxford and Nuffield Department of Medicine", says Dr Davis, CSO of the ARUK Oxford Drug Discovery Institute (ODDI), "Disturbances in the normal function of subcellular organelles has been highlighted as a possible cause of several neurodegenerative diseases and Ira's expertise in the field will provide a major boost to expansion of our understanding of the functional genetics of Parkinson's disease, in particular".

Dr Milosevic, who joins the University from the European Neuroscience Institute – Göttingen, said: "I am honoured to accept the John Black Senior Research Fellowship and excited to be joining the University of Oxford. I am extremely grateful to the John Black Charitable Foundation for providing financial support and for their efforts to promote translational research in Parkinson's disease. I look forward to helping advance their important mission and to collaborating with the exceptional faculty and students at the Nuffield Department of Medicine and Wellcome Centre for Human Genetics. "

About the John Black Charitable Foundation

John Black Charitable Foundation (JBCF) was created out of the Will of the Late John Black. The aim of JBCF is to promote quality research in the areas of Parkinson's disease and Prostate Cancer. Since its inception, JBCF has committed substantial funding for a large number of research projects at many of the UK's leading institutions.

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Celebrating Childhood Cancer Awareness Month

September was Childhood Cancer Awareness Month, and researchers in Department of Paediatrics took action to help raise awareness for this cause.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.